Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 404

1.

Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615.

Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ 3rd, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW; iDCL Study Group.

Diabetes Care. 2020 Apr 3. pii: dc20er06. doi: 10.2337/dc20-er06. [Epub ahead of print] No abstract available.

PMID:
32245747
2.

The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial.

Beck RW, Cleary PA, Backlund JC; Optic Neuritis Study Group.

Ophthalmology. 2020 Apr;127(4S):S174-S181. doi: 10.1016/j.ophtha.2020.01.027.

PMID:
32200819
3.

Effect of Exercise and Meals on Continuous Glucose Monitor Data in Healthy Individuals Without Diabetes.

DuBose SN, Li Z, Sherr JL, Beck RW, Tamborlane WV, Shah VN.

J Diabetes Sci Technol. 2020 Feb 17:1932296820905904. doi: 10.1177/1932296820905904. [Epub ahead of print]

PMID:
32064911
4.

Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. Reply.

Kovatchev BP, Brown SA, Beck RW.

N Engl J Med. 2020 Feb 6;382(6):578. doi: 10.1056/NEJMc1915995. No abstract available.

PMID:
32023383
5.

Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial.

Glassman AR, Beaulieu WT, Stockdale CR, Beck RW, Bressler NM, Labriola LT, Melia M, Oliver K, Sun JK.

Clin Trials. 2020 Jan 27:1740774519894229. doi: 10.1177/1740774519894229. [Epub ahead of print]

PMID:
31984762
6.

Randomized Controlled Trial of Mobile Closed-Loop Control.

Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ 3rd, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW; iDCL Study Group.

Diabetes Care. 2020 Mar;43(3):607-615. doi: 10.2337/dc19-1310. Epub 2020 Jan 14. Erratum in: Diabetes Care. 2020 Apr 3;:.

PMID:
31937608
7.
8.

Nonadjunctive Use of Continuous Glucose Monitoring: The End of Fingersticks?

Beck RW, Brown SA, Lum JW, Kovatchev BP.

Diabetes Technol Ther. 2020 Feb;22(2):67-68. doi: 10.1089/dia.2019.0387. Epub 2019 Nov 15. No abstract available.

PMID:
31657622
9.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group.

N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16.

10.

Advances in technology for management of type 1 diabetes.

Beck RW, Bergenstal RM, Laffel LM, Pickup JC.

Lancet. 2019 Oct 5;394(10205):1265-1273. doi: 10.1016/S0140-6736(19)31142-0. Epub 2019 Sep 15. Review.

PMID:
31533908
11.

Emphasizing Optimal Diabetes Management for All Races/Ethnicities, but Not Race/Ethnicity-Specific Cut Points for Hemoglobin A1c.

Bergenstal RM, Beck RW.

JAMA Ophthalmol. 2019 Aug 22. doi: 10.1001/jamaophthalmol.2019.3233. [Epub ahead of print] No abstract available.

PMID:
31436784
12.

The T1D Exchange Clinic Network and Registry: 10 Years of Enlightenment on the State of Type 1 Diabetes in the United States.

Beck RW, Miller KM, Foster NC.

Diabetes Technol Ther. 2019 Jun;21(6):310-312. doi: 10.1089/dia.2019.0129. No abstract available.

PMID:
31157565
13.

Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.

Shah VN, DuBose SN, Li Z, Beck RW, Peters AL, Weinstock RS, Kruger D, Tansey M, Sparling D, Woerner S, Vendrame F, Bergenstal R, Tamborlane WV, Watson SE, Sherr J.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4356-4364. doi: 10.1210/jc.2018-02763.

PMID:
31127824
14.

Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data.

Leelarathna L, Beck RW, Bergenstal RM, Thabit H, Hovorka R; APCam11, AP@home04, and APCam08 Investigators.

Diabetes Care. 2019 Apr;42(4):e60-e61. doi: 10.2337/dc18-2479. Epub 2019 Feb 6. No abstract available.

PMID:
30728221
15.

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.

Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, Maahs DM, Tamborlane WV, Bergenstal R, Smith E, Olson BA, Garg SK.

Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089/dia.2018.0384. Epub 2019 Jan 18. Erratum in: Diabetes Technol Ther. 2019 Apr;21(4):230.

16.

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.

Beck RW, Bergenstal RM, Cheng P, Kollman C, Carlson AL, Johnson ML, Rodbard D.

J Diabetes Sci Technol. 2019 Jul;13(4):614-626. doi: 10.1177/1932296818822496. Epub 2019 Jan 13.

17.

The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set.

Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C.

Diabetes Technol Ther. 2019 Jan;21(1):1-5. doi: 10.1089/dia.2018.0362. Epub 2018 Dec 21.

18.

Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.

Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks DB, Kowalski A, Brown AS, Heinemann L, Aleppo G, Ryan DB, Riddlesworth TD, Cefalu WT.

Diabetes Care. 2019 Feb;42(2):e29-e30. doi: 10.2337/dci18-0061. Epub 2018 Dec 17. No abstract available.

19.

Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall.

Riddell MC, Zaharieva DP, Tansey M, Tsalikian E, Admon G, Li Z, Kollman C, Beck RW.

Pediatr Diabetes. 2019 Feb;20(1):99-106. doi: 10.1111/pedi.12799. Epub 2018 Dec 13.

PMID:
30467929
20.

CHEIROARTHROPATHY: A COMMON DISORDER IN PATIENTS IN THE T1D EXCHANGE.

Aleppo G, Kanapka LG, Foster NC, Wu M, Clements MA, Rickels MR, McGill JB, Beck RW; T1D Exchange Clinic Network.

Endocr Pract. 2019 Feb;25(2):138-143. doi: 10.4158/EP-2018-0346. Epub 2018 Nov 1.

PMID:
30383489
21.

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.

Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown AS, Close KL.

Diabetes Care. 2019 Mar;42(3):400-405. doi: 10.2337/dc18-1444. Epub 2018 Oct 23.

22.

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.

Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam11 Consortium.

Lancet. 2018 Oct 13;392(10155):1321-1329. doi: 10.1016/S0140-6736(18)31947-0. Epub 2018 Oct 3. Erratum in: Lancet. 2018 Oct 13;392(10155):1310.

23.

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.

Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks DB, Kowalski A, Brown AS, Heinemann L, Aleppo G, Ryan DB, Riddlesworth TD, Cefalu WT.

Diabetes Care. 2018 Nov;41(11):2275-2280. doi: 10.2337/dc18-1581. Epub 2018 Sep 17.

24.

Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry.

Tamborlane WV, Chang P, Kollman C, Klingensmith GJ, Ruedy K, Gal RL, Van Name M, Bacha F, Willi S, Beck RW; Pediatric Diabetes Consortium.

Pediatr Diabetes. 2018 Dec;19(8):1379-1384. doi: 10.1111/pedi.12763. Epub 2018 Oct 10.

PMID:
30175440
25.

Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry.

Shah VN, Wu M, Polsky S, Snell-Bergeon JK, Sherr JL, Cengiz E, DiMeglio LA, Pop-Busui R, Mizokami-Stout K, Foster NC, Beck RW; for T1D Exchange Clinic Registry.

J Diabetes Complications. 2018 Oct;32(10):961-965. doi: 10.1016/j.jdiacomp.2018.08.009. Epub 2018 Aug 10.

PMID:
30121205
26.

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.

Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, Wadwa RP, Ekhlaspour L, Church MM, Weinzimer SA, Jost E, Marcal T, Andre C, Carria L, Swanson V, Lum JW, Kollman C, Woodall W, Beck RW.

Diabetes Care. 2018 Oct;41(10):2155-2161. doi: 10.2337/dc18-0771. Epub 2018 Aug 8.

PMID:
30089663
27.

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2018 Oct 1;136(10):1138-1148. doi: 10.1001/jamaophthalmol.2018.3255. Erratum in: JAMA Ophthalmol. 2019 Apr 1;137(4):467.

28.

Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange.

Polsky S, Wu M, Bode BW, DuBose SN, Goland RS, Maahs DM, Foster NC, Peters AL, Levy CJ, Shah VN, Beck RW.

Diabetes Technol Ther. 2018 Aug;20(8):517-523. doi: 10.1089/dia.2018.0033. Epub 2018 Jul 10.

PMID:
29990438
29.

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.

Rickels MR, DuBose SN, Toschi E, Beck RW, Verdejo AS, Wolpert H, Cummins MJ, Newswanger B, Riddell MC; T1D Exchange Mini-Dose Glucagon Exercise Study Group.

Diabetes Care. 2018 Sep;41(9):1909-1916. doi: 10.2337/dc18-0051. Epub 2018 May 18.

30.

Continuous Glucose Monitors for Insulin Dosing.

Beck RW.

JAMA. 2018 Apr 3;319(13):1383. doi: 10.1001/jama.2018.0185. No abstract available.

PMID:
29614171
31.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections.

Beck RW, Riddlesworth TD.

Ann Intern Med. 2018 Apr 3;168(7):526-527. doi: 10.7326/L17-0706. No abstract available.

PMID:
29610905
32.

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.

Riddlesworth TD, Beck RW, Gal RL, Connor CG, Bergenstal RM, Lee S, Willi SM.

Diabetes Technol Ther. 2018 Apr;20(4):314-316. doi: 10.1089/dia.2017.0455. Epub 2018 Mar 22.

PMID:
29565197
33.

Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels.

Bergenstal RM, Gal RL, Beck RW.

Ann Intern Med. 2018 Feb 6;168(3):232-233. doi: 10.7326/L17-0589. No abstract available.

PMID:
29404586
34.

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002-1009.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2018 Mar;41(3):640. doi: 10.2337/dc18-er03. Epub 2018 Jan 10. No abstract available.

35.

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.

Forlenza GP, Raghinaru D, Cameron F, Wayne Bequette B, Peter Chase H, Paul Wadwa R, Maahs DM, Jost E, Ly TT, Wilson DM, Norlander L, Ekhlaspour L, Min H, Clinton P, Njeru N, Lum JW, Kollman C, Beck RW, Buckingham BA; In-Home Closed-Loop (IHCL) Study Group.

Pediatr Diabetes. 2018 May;19(3):420-428. doi: 10.1111/pedi.12603. Epub 2017 Nov 20.

36.

Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry.

Bacha F, Cheng P, Gal RL, Kollman C, Tamborlane WV, Klingensmith GJ, Manseau K, Wood J, Beck RW; for the Pediatric Diabetes Consortium.

Horm Res Paediatr. 2018;89(1):47-55. doi: 10.1159/000481687. Epub 2017 Oct 31.

PMID:
29131017
37.

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.

Maturi RK, Glassman AR, Liu D, Beck RW, Bhavsar AR, Bressler NM, Jampol LM, Melia M, Punjabi OS, Salehi-Had H, Sun JK; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2018 Jan 1;136(1):29-38. doi: 10.1001/jamaophthalmol.2017.4914.

38.

Corneal Endothelial Cell Loss 3 Years After Successful Descemet Stripping Automated Endothelial Keratoplasty in the Cornea Preservation Time Study: A Randomized Clinical Trial.

Lass JH, Benetz BA, Verdier DD, Szczotka-Flynn LB, Ayala AR, Liang W, Aldave AJ, Dunn SP, McCall T, Mian SI, Navarro LC, Patel SV, Pramanik S, Rosenwasser GO, Ross KW, Terry MA, Kollman C, Gal RL, Beck RW; Cornea Preservation Time Study Group.

JAMA Ophthalmol. 2017 Dec 1;135(12):1394-1400. doi: 10.1001/jamaophthalmol.2017.4970.

39.

Effect of Cornea Preservation Time on Success of Descemet Stripping Automated Endothelial Keratoplasty: A Randomized Clinical Trial.

Rosenwasser GO, Szczotka-Flynn LB, Ayala AR, Liang W, Aldave AJ, Dunn SP, McCall T, Navarro LC, Pramanik S, Ross KW, Stulting RD, Terry MA, Tu EY, Verdier DD, Kollman C, Gal RL, Beck RW, Lass JH; Cornea Preservation Time Study Group.

JAMA Ophthalmol. 2017 Dec 1;135(12):1401-1409. doi: 10.1001/jamaophthalmol.2017.4989.

40.

Abnormal cortical asymmetry as a target for neuromodulation in neuropsychiatric disorders: A narrative review and concept proposal.

Beck RW, Laugharne J, Laugharne R, Woldman W, McLean B, Mastropasqua C, Jorge R, Shankar R.

Neurosci Biobehav Rev. 2017 Dec;83:21-31. doi: 10.1016/j.neubiorev.2017.09.025. Epub 2017 Sep 25. Review.

PMID:
28958599
41.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, Aronson R, Toschi E, Kollman C, Bergenstal R; DIAMOND Study Group.

Ann Intern Med. 2017 Sep 19;167(6):365-374. doi: 10.7326/M16-2855. Epub 2017 Aug 22.

PMID:
28828487
42.

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.

Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM.

Diabetes Care. 2017 Aug;40(8):994-999. doi: 10.2337/dc17-0636.

43.

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.

Beck RW, Riddlesworth TD, Ruedy KJ, Kollman C, Ahmann AJ, Bergenstal RM, Bhargava A, Bode BW, Haller S, Kruger DF, McGill JB, Polonsky W, Price D, Toschi E; DIAMOND Study Group.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):700-708. doi: 10.1016/S2213-8587(17)30217-6. Epub 2017 Jul 12.

PMID:
28711468
44.

Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections.

Riddlesworth T, Price D, Cohen N, Beck RW.

Diabetes Ther. 2017 Aug;8(4):947-951. doi: 10.1007/s13300-017-0281-4. Epub 2017 Jun 14.

45.

Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels.

Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA, Willi SM, Aleppo G, Weinstock RS, Wood J, Rickels M, DiMeglio LA, Bethin KE, Marcovina S, Tassopoulos A, Lee S, Massaro E, Bzdick S, Ichihara B, Markmann E, McGuigan P, Woerner S, Ecker M, Beck RW; T1D Exchange Racial Differences Study Group.

Ann Intern Med. 2017 Jul 18;167(2):95-102. doi: 10.7326/M16-2596. Epub 2017 Jun 13.

PMID:
28605777
46.

Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.

Haymond MW, DuBose SN, Rickels MR, Wolpert H, Shah VN, Sherr JL, Weinstock RS, Agarwal S, Verdejo AS, Cummins MJ, Newswanger B, Beck RW; T1D Exchange Mini-dose Glucagon Study Group.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2994-3001. doi: 10.1210/jc.2017-00591.

PMID:
28591776
47.

Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2017 Aug;40(8):1002-1009. doi: 10.2337/dc16-1990. Epub 2017 May 25. Erratum in: Diabetes Care. 2018 Jan 10;:.

48.

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.

Gross JG, Glassman AR, Klein MJ, Jampol LM, Ferris FL 3rd, Bressler NM, Beck RW.

JAMA Ophthalmol. 2017 Jun 1;135(6):672-673. doi: 10.1001/jamaophthalmol.2017.0969. No abstract available.

49.

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study.

Wallace DK, Kraker RT, Freedman SF, Crouch ER, Hutchinson AK, Bhatt AR, Rogers DL, Yang MB, Haider KM, VanderVeen DK, Siatkowski RM, Dean TW, Beck RW, Repka MX, Smith LE, Good WV, Hartnett ME, Kong L, Holmes JM; Pediatric Eye Disease Investigator Group (PEDIG).

JAMA Ophthalmol. 2017 Jun 1;135(6):654-656. doi: 10.1001/jamaophthalmol.2017.1055.

50.

The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.

Polonsky WH, Hessler D, Ruedy KJ, Beck RW; DIAMOND Study Group.

Diabetes Care. 2017 Jun;40(6):736-741. doi: 10.2337/dc17-0133. Epub 2017 Apr 7.

PMID:
28389582

Supplemental Content

Support Center